Antimicrobials for diabetic foot infections
Clinical design of trials for antimicrobials intended for the treatment of diabetic foot infections will be a topic of FDA's Anti-Infective Drugs Advisory Committee on Oct. 28. The committee will meet in closed session from 8 a.m. to 12 p.m., and the discussion on diabetic infections will begin at 1 p.m...
You may also be interested in...
The leadership of top Indian firms recounted at the IPA Forum how they got together on a joint 45-minute call daily in the early phase of the pandemic to collaborate and ensure uninterrupted supplies of medicines both in India and globally. The executives also shared views on telemedicine and digitalization trends at the event.
Medtech Insight spoke to attorney Greg Dadika about mass tort litigation, including industry trends, how to find the right law firm, and when it’s the right time to settle a suit. See what Dadika, an attorney at the law firm Greenberg Traurig LLP, said about it here.
Sotagliflozin Hail Mary? Lexicon Seeks Opportunity For Formal Hearing On FDA Intent To Deny Approval
After complete response letter, Lexicon triggers rarely used mechanism for formal hearing, prompting US FDA to publicly list its problems with the proposed type 1 diabetes drug, for which Sanofi had originally sought approval.